Trial of Iressa in Prostate Cancer Patients

NCT00265070 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Gefitinib

Sponsor

AstraZeneca